Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US
24 Nov 2022 //
INDIANPHARMAPOST
Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US
24 Nov 2022 //
ECONOMIC TIMES
Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™
31 Mar 2021 //
PRNEWSWIRE